Market Cap (In CNY)
1.51 Billion
Revenue (In CNY)
579.33 Million
Net Income (In CNY)
-93.07 Million
Avg. Volume
2.94 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 3.17-5.97
- PE
- -
- EPS
- -
- Beta Value
- 0.166
- ISIN
- CNE100002QC3
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Shuang Liu
- Employee Count
- -
- Website
- https://www.tszy.com.cn
- Ipo Date
- 2017-05-19
- Details
- Tiansheng Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and circulation activities. It offers products in various categories, including respiratory, digestive, cardiovascular and cerebrovascular, pediatric, gynecological, orthopedic, tumor, hepatobiliary, blood, surgery, diabetes, and others. The company was founded in 2001 and is based in Chongqing, China.
More Stocks
-
R35Roku, Inc.
R35
-
HNLDr. Hönle AG
HNL
-
AOMDAlstom SA
AOMD
-
4583
-
PPH
-
600968
-
ELECTHERMElectrotherm (India) Limited
ELECTHERM
-
MARK